Impact of Interleukin-10 Gene Polymorphisms on Survival in Patients with Colorectal Cancer.
10.3346/jkms.2013.28.9.1302
- Author:
Wen Chien TING
1
;
Lu Min CHEN
;
Li Chia HUANG
;
Mann Jen HOUR
;
Yu Hsuan LAN
;
Hong Zin LEE
;
Bang Jau YOU
;
Ta Yuan CHANG
;
Bo Ying BAO
Author Information
1. Department of Colorectal Surgery, China Medical University Hospital, Taichung, Taiwan.
- Publication Type:Original Article ; Research Support, Non-U.S. Gov't
- Keywords:
Colorectal Neoplasms;
Inflammation;
Interleukin-10;
Polymorphism;
Survival
- MeSH:
Aged;
Alleles;
Carcinoembryonic Antigen/blood;
Cell Differentiation;
Colorectal Neoplasms/*genetics/mortality/pathology;
Female;
Genotype;
Homozygote;
Humans;
Interleukin-10/*genetics;
Kaplan-Meier Estimate;
Lymphatic Metastasis;
Male;
Middle Aged;
Neoplasm Staging;
*Polymorphism, Single Nucleotide;
Regression Analysis;
Tumor Markers, Biological/genetics
- From:Journal of Korean Medical Science
2013;28(9):1302-1306
- CountryRepublic of Korea
- Language:English
-
Abstract:
Chronic inflammation is thought to be the leading cause of colorectal cancer, and interleukin-10 (IL10) has been identified as a potent immunomodulatory cytokine that regulates inflammatory responses in the gastrointestinal tract. Although several single nucleotide polymorphisms (SNPs) in IL10 have been associated with the risk of colorectal cancer, their prognostic significance has not been determined. Two hundred and eighty-two colorectal cancer patients were genotyped for two candidate cancer-associated SNPs in IL10. The associations of these SNPs with distant metastasis-free survival and overall survival were evaluated by Kaplan-Meier analysis and Cox regression model. The minor homozygote GG genotype of IL10 rs3021094 was significantly associated with a 3.30-fold higher risk of death compared with the TT+TG genotypes (P=0.011). The patients with IL10 rs3021094 GG genotype also had a poorer overall survival in Kaplan-Meier analysis (log-rank P=0.007) and in multivariate Cox regression model (P=0.044) adjusting for age, gender, carcinoembryonic antigen levels, tumor differentiation, stage, lymphovascular invasion, and perineural invasion. In conclusion, our results suggest that IL10 rs3021094 might be a valuable prognostic biomarker for colorectal cancer patients.
